Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials

Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling

(2012) R. Loch Macdonald et al.   STROKE

Quality of Life and Healthcare Resource Use Associated With Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage

(2012) R. Loch Macdonald et al.   STROKE

Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats

(2011) Gang Chen et al.   BRAIN RESEARCH

Effect of clazosentan, a selective endothelin A receptor antagonist, and tezosentan, a dual endothelin A/B antagonist, on pulsatile shear stress induced constriction of the iliac in the anaesthetized pig

(2011) Therese Ruane-O’Hora et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

(2011) R Loch Macdonald et al.   LANCET NEUROLOGY

Method of Aneurysm Treatment Does Not Affect Clot Clearance After Aneurysmal Subarachnoid Hemorrhage

(2011) George M. Ibrahim et al.   NEUROSURGERY

Cerebral Infarction After Subarachnoid Hemorrhage Contributes to Poor Outcome by Vasospasm-Dependent and -Independent Effects

(2011) Mervyn D.I. Vergouwen et al.   STROKE

Dissociation of Vasospasm and Secondary Effects of Experimental Subarachnoid Hemorrhage by Clazosentan

(2011) Mohammed Sabri et al.   STROKE

Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage

(2011) Diego Castanares-Zapatero et al.   Annals of Intensive Care

Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage

(2010) Alejandro A Rabinstein et al.   LANCET NEUROLOGY

Improved Cognitive Outcomes With Endovascular Coiling of Ruptured Intracranial Aneurysms

(2010) Richard B. Scott et al.   STROKE

Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage

(2010) Timour Al-Khindi et al.   STROKE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group

(2009) Andrea D. Furlan et al.   SPINE

Do Endothelin-Receptor Antagonists Prevent Delayed Neurological Deficits and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage?

(2009) Andreas Kramer et al.   STROKE

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage

(2009) Joshua B. Bederson et al.   STROKE

New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage

(2008) R. Webster Crowley et al.   DRUG DISCOVERY TODAY

Microthrombosis after Aneurysmal Subarachnoid Hemorrhage: An Additional Explanation for Delayed Cerebral Ischemia

(2008) Mervyn DI Vergouwen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats

(2008) Gerrit A. Schubert et al.   JOURNAL OF NEUROSURGERY

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

(2008) R. Loch Macdonald et al.   STROKE

Subarachnoid Hemorrhage: Is It Time for a New Direction?

(2008) J. Cahill et al.   STROKE